AC Immune S.A.

NASDAQ: ACIU · Real-Time Price · USD
2.15
0.02 (0.94%)
At close: Aug 15, 2025, 3:59 PM
2.12
-1.17%
After-hours: Aug 15, 2025, 04:45 PM EDT
0.94%
Bid 2.07
Market Cap 212.23M
Revenue (ttm) 28.3M
Net Income (ttm) -52.08M
EPS (ttm) -0.62
PE Ratio (ttm) -3.46
Forward PE -4.86
Analyst Buy
Ask 2.46
Volume 68,708
Avg. Volume (20D) 135,690
Open 2.17
Previous Close 2.13
Day's Range 2.09 - 2.19
52-Week Range 1.43 - 3.98
Beta 1.65

About ACIU

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACIU
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ACIU stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

AC Immune S.A. has released their quartely earnings on Aug 5, 2025:
  • Revenue of $1.54M misses estimates by $2.17M, with 102.61% YoY growth.
  • EPS of -0.25 misses estimates by -0.05, with 0.00% YoY growth.
  • Next Earnings Release

    AC Immune S.A. is scheduled to release its earnings on Nov 4, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    9 months ago
    +13.42%
    AC Immune shares are trading higher after the comp... Unlock content with Pro Subscription
    11 months ago
    +5.81%
    AC Immune shares are trading higher after the company announced it will receive the second ReTain-related milestone payment under its agreement with Janssen Pharmaceuticals.